Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma
Multiple myeloma is a prevalent and incurable disease, despite the development of new and effective drugs. The recent development of chimeric antigen receptor (CAR)-T cell therapy has shown impressive results in the treatment of patients with relapsed or refractory hematological B cell malignancies...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Ferrata Storti Foundation
2020-01-01
|
| Ráidu: | Haematologica |
| Liŋkkat: | https://haematologica.org/article/view/9604 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|